Please note that IPD sharing statement and summary results sections will be added to the ANZCTR form in the coming weeks in order to comply with the updated WHO Trial Registration Data Set.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Trial ID
ACTRN12605000227695
Ethics application status
Approved
Date submitted
25/08/2005
Date registered
26/08/2005
Date last updated
19/01/2006
Type of registration
Retrospectively registered

Titles & IDs
Public title
Contribution of respiratory loading to sleep architecture abnormalities in hypercapnic Chronic Obstructive Airways Disease
Scientific title
Contribution of respiratory loading to sleep architecture abnormalities in hypercapnic Chronic Obstructive Airways Disease
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Chronic Obstructive Airways Disease 313 0
Condition category
Condition code
Respiratory 357 357 0 0
Other respiratory disorders / diseases

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Nil
Intervention code [1] 256 0
None
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 413 0
Correlation between instantaneous respiratory muscle load as a proportion of respiratory mucle peak reserve
Timepoint [1] 413 0
Primary outcome [2] 414 0
Arousal from sleep
Timepoint [2] 414 0
Secondary outcome [1] 888 0
Nil
Timepoint [1] 888 0

Eligibility
Key inclusion criteria
Severe COPD Hypercapnia
Minimum age
Not stated
Maximum age
Not stated
Gender
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
No exclusion criteria

Study design
Purpose
Natural history
Duration
Cross-sectional
Selection
Convenience sample
Timing
Prospective
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)

Funding & Sponsors
Funding source category [1] 416 0
Government body
Name [1] 416 0
NHMRC
Address [1] 416 0
Country [1] 416 0
Australia
Primary sponsor type
Individual
Name
Fergal Oâ¿¿Donoghue
Address
Country
Secondary sponsor category [1] 336 0
Individual
Name [1] 336 0
Doug McEvoy
Address [1] 336 0
Country [1] 336 0

Ethics approval
Ethics application status
Approved

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 35331 0
Address 35331 0
Country 35331 0
Phone 35331 0
Fax 35331 0
Email 35331 0
Contact person for public queries
Name 9445 0
Fergal O'Donoghue
Address 9445 0
Institute for Breathing and Sleep
Department of Respiratory and Sleep Medicine
Austin Health
Heidelberg VIC 3084
Country 9445 0
Australia
Phone 9445 0
+61 3 94963688
Fax 9445 0
+61 3 94965124
Email 9445 0
Fergal.O'Donoghue@austin.org.au
Contact person for scientific queries
Name 373 0
Fergal O'Donoghue
Address 373 0
Institute for Breathing and Sleep
Department of Respiratory and Sleep Medicine
Austin Health
Heidelberg VIC 3084
Country 373 0
Australia
Phone 373 0
+61 3 94963688
Fax 373 0
+61 3 94965124
Email 373 0
Fergal.O'Donoghue@austin.org.au